Nucleoside reverse transcriptase inhibitors (NRTIs)

M 106 Pill - white round, 10mm

Pill with imprint M 106 is White, Round and has been identified as Zidovudine 300 mg. It is supplied by Mylan Pharmaceuticals Inc.

Zidovudine is used in the treatment of Reduction of Perinatal Transmission of HIV; HIV Infection; Nonoccupational Exposure; Occupational Exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Zidovudine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Zidovudine (oral/injection) (Zidovudine (oral/injection) [ zye-doe-vyoo-deen ])-M 106-300 mg-White-Round
Zidovudine (oral/injection) (Zidovudine (oral/injection) [ zye-doe-vyoo-deen ])-M 106-300 mg-White-Round

Zidovudine (oral/injection)
Generic Name: zidovudine (oral/injection) [ zye-doe-vyoo-deen ]
Imprint: M 106
Strength: 300 mg
Color: White
Size: 10.00 mm
Shape: Round
Availability: Prescription only
Drug Class: Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 00378-6106 (Discontinued)
Inactive Ingredients: Magnesium stearate, Microcrystalline cellulose, Sodium starch glycolate type A potato, Titanium dioxide,
Latest News
Related Drugs